PrognostiX, a privately-held spin out of the Cleveland Clinic Foundation, is focused on cardiovascular disease management. The company's CardioMPO™ test, which aids in the diagnosis of near-term heart attack and cardiac death risk is the first FDA-cleared diagnostic of its kind. PrognostiX's proprietary product pipeline includes valuable, high-margin cardiovascular and inflammatory biomarkers licensed to it exclusively by the Cleveland Clinic, the world's most respected cardiovascular center. The company operates a CLIA-certified and CAP-accredited specialty reference laboratory, enabling it to bring promising new cardiovascular biomarkers to market
View Top Employees from PrognostixWebsite | http://www.prognostix.com |
Revenue | $7.8 million |
Employees | 6 (0 on RocketReach) |
Address | 10265 Carnegie Ave, Cleveland, Ohio 44106, US |
Phone | (216) 445-7469 |
Fax | (866) 449-0960 |
Technologies | |
Industry | Wellness and Fitness Services, Business Services General, Business Services |
SIC | SIC Code 807 Companies, SIC Code 8071 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Prognostix employee's phone or email?
The Prognostix annual revenue was $7.8 million in 2023.
Prognostix is based in Cleveland, Ohio.
The NAICS codes for Prognostix are [621, 62].
The SIC codes for Prognostix are [807, 8071, 80].